NanoSyrinx is a cutting-edge synthetic biology company creating the next generation of targeted drug delivery systems to address challenges in the biologic delivery sector.
| Website | http://www.nanosyrinx.com |
| Revenue | $1 million |
| Employees | 31 (18 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology, Drug Delivery, Pharmaceuticals, Healthcare |
| Keywords | Targeted Drug Delivery, Drug Delivery, Drug Delivery Systems, Advanced Drug Delivery, Synthetic Biology, Controlled Release, Novel Drug Delivery, Nanomedicine, Precision Medicine, Next Generation Therapeutics, Nanotechnology, Biotechnology, Drug Development, Innovative Therapies, Therapeutics, Biopharma, Pharmaceutical, Biosensors, Pharmaceutical Technology |
| Competitors | CureVac, Wave Life Sciences, Scribetx, Geno, Arrakis Therapeutics, Ribometrix Inc., Aptamer Group, Treventis Corporation, Ribon Therapeutics, Disarm Therapeutics +37 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular NanoSyrinx employee's phone or email?
NanoSyrinx Questions
The NanoSyrinx annual revenue was $1 million in 2026.
Marie McAvoy is the Chief Scientific Officer of NanoSyrinx.
18 people are employed at NanoSyrinx.
The NAICS codes for NanoSyrinx are [54171, 541713, 5417, 54, 541].
The SIC codes for NanoSyrinx are [87, 873].
Top NanoSyrinx Employees
-
Marie McAvoy
Chief Scientific Officer at NanoSyrinx
United Kingdom1 -
James Lapworth
Chief Business Officer at NanoSyrinx
United Kingdom2 -
Lucy Jones
Board Director at NanoSyrinx
United Kingdom3 -
Tom Farrell
Chief Executive Officer at NanoSyrinx
Coventry, GB55+ -
1
-
1
-
Amy O'Reilly
Assoc. Principal Scientist at NanoSyrinx
United Kingdom1
Related Companies
G2Crowd Trusted
300K+
Plugin Users
